共 50 条
- [1] INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIALJOURNAL OF UROLOGY, 2022, 207 (05): : E1008 - E1008Patel, SunilCollins, ConnieSingla, NirmishGabrielson, AndrewBivalacqua, Trinity J.Hahn, NoahKates, Max
- [2] A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladderANNALS OF ONCOLOGY, 2024, 35 : S1143 - S1143DeCastro, G. J.Stein, M.Abate-Shen, C.Miles, C.Gray, J.Joffe, B.Anderson, C.Lenis, A.McKiernan, J. M. M.
- [3] Intravesical gemcitabine and docetaxel in the treatment of BCG-naive non-muscle invasive urothelial carcinoma of the bladder: Updates from a phase 2 trial.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41Patel, Sunil H.Gabrielson, AndrewCollins, ConnieSingla, NirmishBivalacqua, TrinityHahn, Noah M.Kates, Max R.
- [4] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDERJOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623DeCastro, G. JoelAnderson, ChristopherKates, MaxBuckley-Matura, BridgetSui, WilsonLee, Shing M.Holder, DaraVirk, RenuDrake, CharlesAbate-Shen, CoryMcKiernan, James
- [5] Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)DeCastro, Guarionex JoelAnderson, Christopher B.Abate-Shen, CoryGray, JillianIngram, JustinStein, Mark N.McKiernan, James M.
- [6] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDERJOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248Joffe, Benjamin I.Christin, John R.Le Coz, ClementinePak, Jamie S.Laplaca, CarolineReyes, Helena VilaDeCastro, G. JoelAnderson, Christopher B.Abate-Shen, CoryMcKiernan, James M.Lenis, Andrew T.
- [7] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDERJOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176DeCastro, GuarionexSui, WilsonPak, JamieAbate-Shen, CoryLee, ShingAnderson, ChristopherHolder, DaraMcKiernan, James
- [8] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder CancerBLADDER CANCER, 2015, 1 (01) : 65 - 72Steinberg, Ryan L.Thomas, Lewis J.O'Donnell, Michael A.Nepple, Kenneth G.
- [9] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCERJOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301Steinberg, RyanThomas, LewisO'Donnell, MichaelNepple, Kenneth
- [10] Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder CancerLIFE-BASEL, 2024, 14 (07):Bakula, MirkoHudolin, TvrtkoKnezevic, NikolaZimak, ZoranAndelic, JerkoJuric, IlijaGamulin, MarijaGnjidic, MilenaKastelan, Zeljko